Vazquez L, Encinas M, Morin L, Vilches P, Gutierrez N, Garcia-Sanz R, Caballero D, Hurle A. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. Haematologica 1999; 84(3):231-236.